Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
30
Apr |
Genome-Informed Medicine Steps Closer As Researchers Assess One Man’s Disease Risks And Drug ReactionsCategory: Genetics | Leave a Comment |
Personalized medical care that takes into account information derived from sequencing a patient’s entire genome came a step closer this week as US researchers revealed how they used a healthy man’s genome to assess his risk of contracting dozens of diseases and likely responses to several common medications…
|
30
Apr |
Fluorescent Compounds Make Tumors GlowCategory: Cancer / Oncology | Leave a Comment |
A series of novel imaging agents could light up tumors as they begin to form - before they turn deadly - and signal their transition to aggressive cancers…
|
30
Apr |
A Polymer Pill To Improve Lung Cancer DiagnosisCategory: Lung Cancer | Leave a Comment |
Doctors may soon be able to diagnose lung cancer more effectively thanks to research performed at the National Institute of Standards and Technology (NIST), where scientists have found ways both to increase the accuracy of computed tomography (CT) scans and to lessen the amount of time necessary to perceive telltale changes in lung tissue…
|
30
Apr |
ASP Sterrad Technology Approved By AFSSAPS For Total Inactivation Of PrionsCategory: Neurology / Neuroscience | Leave a Comment |
Advanced Sterilization Products (ASP) announced today that the French Health Products Safety Agency, AFSSAPS, will approve the low-temperature hydrogen peroxide gas plasma STERRAD® NX™ and the STERRAD® 100NX™ Sterilization Systems for total inactivation of prions…
|
29
Apr |
World First Remote Heart Surgery Using Robotic ArmCategory: Cardiovascular / Cardiology | Leave a Comment |
A pioneering world first robotics system operation is to be conducted at Glenfield Hospital Leicester thanks to expertise at the University of Leicester and University Hospitals of Leicester…
|
29
Apr |
AstraZeneca Settles Drug Marketing Lawsuit, Plea Deal Rejected For Possibly Defective Heart Device MakerCategory: Litigation / Medical Malpractice | Leave a Comment |
The New York Times: AstraZeneca has settled a case and agreed to pay $520 million after federal investigations into its marketing practices for a schizophrenia drug, Seroquel. The announcement came Tuesday from Attorney General Eric Holder…
|
29
Apr |
FDA Clears Xlumena’s NAVIX(TM) Access DeviceCategory: GastroIntestinal / Gastroenterology | Leave a Comment |
Xlumena, a privately held provider of innovative technology for gastroenterologists/interventional endoscopists, announced it has received clearance from the US Food and Drug Administration (FDA) to market its NAVIX™ Access Device…
|
29
Apr |
Use And Costs Of Diagnostic Imaging Increasing For Patients With CancerCategory: MRI / PET / Ultrasound | Leave a Comment |
From 1999 through 2006 the use of diagnostic imaging for Medicare patients with cancer increased, with use of positron emission tomography (PET) increasing the most significantly, according to a study in the April 28 issue of JAMA. Imaging costs for these patients also increased, outpacing the rate of increase in total costs among Medicare beneficiaries with cancer…
|
29
Apr |
‘Cardiac Electrophysiology Clinics’ Introduced By ElsevierCategory: Cardiovascular / Cardiology | Leave a Comment |
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces a new addition to the Clinics of North America series - Cardiac Electrophysiology Clinics. Under the expert guidance of Consulting Editors Dr. Ranjan Thakur and Dr…
|
29
Apr |
CME: Pancreatic CancerCategory: Medic | Leave a Comment |
(No abstract is available for this citation)